Endothelial dependence of matrix metalloproteinase-mediated vascular hyporeactivity caused by lipopolysaccharide

European Journal of Pharmacology

Volumn 582, Issue 1-3, 2008, Pages 116-122

  Cena, Jonathan ^a   Lalu, Manoj M ^a   Rosenfelt, Cory ^a   Schulz, Richard ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Endotoxemia; Lipopolysaccharide; Matrix metalloproteinase; Septic shock; Vascular biology

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; DOXYCYCLINE; ILOMASTAT; MATRIX METALLOPROTEINASE; MATRIX METALLOPROTEINASE INHIBITOR; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE INHIBITOR; PHENYLEPHRINE;

ANIMAL TISSUE; ARTERY TONE; ARTICLE; BLOOD VESSEL REACTIVITY; CONTROLLED STUDY; DRUG MECHANISM; ENZYME ACTIVITY; ENZYME INHIBITION; MALE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; RAT; SEPSIS; VASCULAR ENDOTHELIUM; VASCULAR RING;

ANIMALS; AORTA; DIPEPTIDES; DOXYCYCLINE; ENDOTHELIUM, VASCULAR; LIPOPOLYSACCHARIDES; MALE; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASES; MUSCLE CONTRACTION; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE SYNTHASE; PHENYLEPHRINE; RATS; RATS, SPRAGUE-DAWLEY;

EID: 39149106425     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2007.12.019     Document Type: Article

References (46)

1. Balligand J.L., Ungureanu-Longrois D., Simmons W.W., Pimental D., Malinski T.A., Kapturczak M., Taha Z., Lowenstein C.J., Davidoff A.J., and Kelly R.A. Cytokine-inducible nitric oxide synthase (iNOS) expression in cardiac myocytes. Characterization and regulation of iNOS expression and detection of iNOS activity in single cardiac myocytes in vitro. J. Biol. Chem. 269 (1994) 27580-27588
2. Boos C.J., Goon P.K., and Lip G.Y. The endothelium, inflammation, and coagulation in sepsis. Clin. Pharmacol. Ther. 79 (2006) 20-22
3. Buckley J.F., Singer M., and Clapp L.H. Role of KATP channels in sepsis. Cardiovasc. Res. 72 (2006) 220-230
4. Busse R., and Mulsch A. Induction of nitric oxide synthase by cytokines in vascular smooth muscle cells. FEBS Lett. 275 (1990) 87-90
5. Cheung P.-Y., Sawicki G., Wozniak M., Wang W., Radomski M.W., and Schulz R. Matrix metalloproteinase-2 contributes to ischemia-reperfusion injury in the heart. Circulation 101 (2000) 1833-1839
6. 2+ entry mechanisms of vascular contraction. J. Vasc. Surg. 40 (2004) 1001-1010
7. Chow A.K., Cena J., El-Yazbi A.F., Crawford B.D., Holt A., Cho W.J., Daniel E.E., and Schulz R. Caveolin-1 inhibits matrix metalloproteinase-2 in the heart. J. Mol. Cell. Cardiol. 42 (2007) 896-901
8. Chow A.K., Cena J., and Schulz R. Acute actions and novel targets of matrix metalloproteinases in the heart and vasculature. Br. J. Pharmacol. 152 (2007) 189-205
9. Crowley S.R. The pathogenesis of septic shock. Heart Lung 25 (1996) 124-134
10. Fernandez-Patron C., Radomski M.W., and Davidge S.T. Vascular matrix metalloproteinase-2 cleaves big endothelin-1 yielding a novel vasoconstrictor. Circ. Res. 85 (1999) 906-911
11. Fernandez-Patron C., Stewart K.G., Zhang Y., Koivunen E., Radomski M.W., and Davidge S.T. Vascular matrix metalloproteinase-2-dependent cleavage of calcitonin gene-related peptide promotes vasoconstriction. Circ. Res. 87 (2000) 670-676
12. Fleming I., Gray G.A., and Stoclet J.C. Influence of endothelium on induction of the l-arginine-nitric oxide pathway in rat aortas. Am. J. Physiol. 264 (1993) 1200-1207
13. Galley H.F., and Webster N.R. Physiology of the endothelium. Br. J. Anaesth. 93 (2004) 105-113
14. Golub L.M., Lee H.M., Ryan M.E., Giannobile W.V., Payne J., and Sorsa T. Tetracyclines inhibit connective tissue breakdown by multiple non-antimicrobial mechanisms. Adv. Dent. Res. 12 (1998) 12-26
15. Groeneveld P.H., Kwappenberg K.M., Langermans J.A., Nibbering P.H., and Curtis L. Nitric oxide (NO) production correlates with renal insufficiency and multiple organ dysfunction syndrome in severe sepsis. Intensive Care Med. 22 (1996) 1197-1202
16. Heussen C., and Dowdle E.B. Electrophoretic analysis of plasminogen activators in polyacrylamide gels containing sodium dodecyl sulfate and copolymerized substrates. Anal. Biochem. 102 (1980) 196-202
17. Hotchkiss R.S., and Karl I.E. Endothelial cell apoptosis in sepsis: a case of habeas corpus?. Crit. Care Med. 32 (2004) 901-902
18. Julou-Schaeffer G., Gray G.A., Fleming I., Schott C., Parratt J.R., and Stoclet J.C. Loss of vascular responsiveness induced by endotoxin involves l-arginine pathway. Am. J. Physiol. 259 (1990) 1038-1043
19. Kim H., and Koh G. Lipopolysaccharide activates matrix metalloproteinase-2 in endothelial cells through an NF-kappaB-dependent pathway. Biochem. Biophys. Res. Commun. 269 (2000) 401-405
20. Kumar A., Haery C., and Parrillo J. Myocardial dysfunction in septic shock: Part I. clinical manifestation of cardiovascular dysfunction. J. Cardiothorac. Vasc. Anesth. 15 (2001) 364-376
21. Lalu M.M., Gao C.Q., and Schulz R. Matrix metalloproteinase inhibitors attenuate endotoxemia induced cardiac dysfunction: a potential role for MMP-9. Mol. Cell. Biochem. 251 (2003) 61-66
22. Lalu M.M., Csont T., and Schulz R. Matrix metalloproteinase activities are altered in the heart and plasma during endotoxemia. Crit. Care Med. 32 (2004) 1332-1337
23. Lalu M.M., Cena J., Chowdhury R., Lam A., and Schulz R. Matrix metalloproteinases contribute to endotoxin and interleukin-1beta induced vascular dysfunction. Br. J. Pharmacol. 149 (2006) 31-42
24. Lei M.G., and Morrison D.C. Differential expression of caveolin-1 in lipopolysaccharide-activated murine macrophages. Infect. Immun. 68 (2000) 5084-5089
25. Macarthur H., Westfall T.C., Riley D.P., Misko T.P., and Salvemini D. Inactivation of catecholamines by superoxide gives new insights on the pathogenesis of septic shock. Proc. Natl. Acad. Sci. U. S. A. 97 (2000) 9753-9758
26. Mandal M., Mandal A., Das S., Chakraborti T., and Sajal C. Clinical implications of matrix metalloproteinases. Mol. Cell. Biochem. 252 (2003) 305-329
27. McCall T.B., Palmer R.M., and Moncada S. Induction of nitric oxide synthase in rat peritoneal neutrophils and its inhibition by dexamethasone. Eur. J. Immunol. 21 (1991) 2523-2527
28. Nakaki T., Otsuka Y., Nakayama M., and Kato R. Endothelium-accelerated hyporesponsiveness of norepinephrine-elicited contraction of rat aorta in the presence of bacterial lipopolysaccharide. Eur. J. Pharmacol. 219 (1992) 311-318
29. Nakamura T., Ebihara I., Shimada N., Shoji H., and Koide H. Modulation of plasma metalloproteinase-9 concentrations and peripheral blood monocyte mRNA levels in patients with septic shock: effect of fiber-immobilized polymyxin B treatment. Am. J. Med. Sci. 316 (1998) 355-360
30. Ochoa J.B., Udekwu A., Billiar T.R., Curran R.D., Cerra F.B., Simmons R.L., and Peitzman A.B. Nitrogen oxide levels in patients after trauma and during sepsis. Ann. Surg. 214 (1991) 621-626
31. Okamoto T., Akaike T., Sawa T., Miyamoto Y., van der Vliet A., and Maeda H. Activation of matrix metalloproteinases by peroxynitrite-induced protein S-glutathiolation via disulfide S-oxide formation. J. Biol. Chem. 276 (2001) 29596-29602
32. Paemen L., Jansen P.M., Proost P., Van Damme J., Opdenakker G., Hack E., and Taylor F.B. Induction of gelatinase B and MCP-2 in baboons during sublethal and lethal bacteraemia. Cytokine. 9 (1997) 412-415
33. Pugin J., Widmer M.C., Kossodo S., Liang C.M., Preas H.L., and Suffredini A.F. Human neutrophils secrete gelatinase B in vitro and in vivo in response to endotoxin and proinflammatory mediators. Am. J. Respir. Cell Mol. Biol. 20 (1999) 458-464
34. Puyraimond A., Fridman R., Lemesle M., Arbeille B., and Menashi S. MMP-2 colocalizes with caveolae on the surface of endothelial cells. Exp. Cell Res. 262 (2001) 28-36
35. Radomski M.W., Palmer R.M., and Moncada S. Glucocorticoids inhibit the expression of an inducible, but not the constitutive, nitric oxide synthase in vascular endothelial cells. Proc. Natl. Acad. Sci. U. S. A. 87 (1990) 10043-10047
36. + channels: relevance to varicose vein formation. J. Vasc. Surg. 45 (2007) 373-380
37. Rees D.D., Cellek S., Palmer R.M., and Moncada S. Dexamethasone prevents the induction by endotoxin of a nitric oxide synthase and the associated effects on vascular tone: an insight into endotoxin shock. Biochem. Biophys. Res. Commun. 173 (1990) 541-547
38. Schulz R. Intracellular targets of matrix metalloproteinase-2 in cardiac disease: rationale and therapeutic approaches. Annu. Rev. Pharmacol. Toxicol. 47 (2007) 211-242
39. 2+-independent nitric oxide in the myocardium. Br. J. Pharmacol. 105 (1992) 575-580
40. Steinberg J., Halter J., Schiller H., Gatto L., Carney D., Lee H.M., Golub L., and Nieman G. Chemically modified tetracycline prevents the development of septic shock and acute respiratory distress syndrome in a clinically applicable porcine model. Shock 24 (2005) 348-356
41. Sung M.M., Schulz C.G., Wang W., Sawicki G., Bautista-Lopez N.L., and Schulz R. Matrix metalloproteinase-2 degrades the cytoskeletal protein α-actinin in peroxynitrite mediated myocardial injury. J. Mol. Cell. Cardiol. 43 (2007) 429-436
42. Szabo C., Salzman A.L., and Ischiropoulos H. Endotoxin triggers the expression of an inducible isoform of nitric oxide synthase and the formation of peroxynitrite in the rat aorta in vivo. FEBS Lett. 363 (1995) 235-238
43. Thiemermann C. Nitric oxide and septic shock. Gen. Pharmacol. 29 (1997) 159-166
44. van Beusekom H.M., Post M.J., Whelan D.M., de Smet B.J., Duncker D.J., and van der Giessen W.J. Metalloproteinase inhibition by batimastat does not reduce neointimal thickening in stented atherosclerotic porcine femoral arteries. Cardiovasc. Radiat. Med. 4 (2003) 186-191
45. Warrillow S., Egi M., and Bellomo R. Randomized, double-blind, placebo-controlled crossover pilot study of a potassium channel blocker in patients with septic shock. Crit. Care Med. 34 (2006) 980-985
46. Xie B., Dong Z., and Fidler I.J. Regulatory mechanisms for the expression of type IV collagenases/gelatinases in murine macrophages. J. Immunol. 152 (1994) 3637-3644